1994
DOI: 10.1096/fasebj.8.8.8181671
|View full text |Cite
|
Sign up to set email alerts
|

Nitric oxide generation from streptozotocin 1

Abstract: Streptozotocin (STZ), a diabetogenic agent, is thought to damage pancreatic beta-cells by activating immune mechanisms and by alkylating DNA. In the present study, we demonstrated that STZ can produce nitric oxide (NO), a bioregulatory and cytotoxic molecule. When STZ was dissolved in a sodium phosphate buffer (50 mM, pH 7.4) and irradiated with a 22 W circular fluorescent light, nitrite and nitrate, stable oxidation products of NO, were produced. The wavelengths of light most responsible for the photo-decompo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
72
1
1

Year Published

1998
1998
2013
2013

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 119 publications
(77 citation statements)
references
References 42 publications
3
72
1
1
Order By: Relevance
“…STZ has also been widely used, but only inhibits O-GlcNAcase at very high concentrations (Toleman et al 2006;Gao et al 2000;Liu et al 2002;Okuyama and Yachi 2001;Roos et al 1998). It is important to note that STZ is also a DNAalkylating agent and can release nitric oxide, making it difficult to determine whether the observed effects are due to O-GlcNAcase inhibition or STZ toxicity (Kwon et al 1994). Alloxan has been suggested to inhibit O-GlcNAcase (Lee et al 2006), but has been reported to also inhibit OGT and as such should be used with extreme caution Macauley et al 2005).…”
Section: Murine Models and The Ogt F/ymer-cre-2a-gfp Cell Linementioning
confidence: 99%
“…STZ has also been widely used, but only inhibits O-GlcNAcase at very high concentrations (Toleman et al 2006;Gao et al 2000;Liu et al 2002;Okuyama and Yachi 2001;Roos et al 1998). It is important to note that STZ is also a DNAalkylating agent and can release nitric oxide, making it difficult to determine whether the observed effects are due to O-GlcNAcase inhibition or STZ toxicity (Kwon et al 1994). Alloxan has been suggested to inhibit O-GlcNAcase (Lee et al 2006), but has been reported to also inhibit OGT and as such should be used with extreme caution Macauley et al 2005).…”
Section: Murine Models and The Ogt F/ymer-cre-2a-gfp Cell Linementioning
confidence: 99%
“…Whereas STZ induced nitrite generation in pancreas ß-cells, was attenuated by FG. Much evidence supports the hypothesis that high-output NO by iNOS provokes deleterious consequences in inflammatory diseases (3)(4)(5)23). The ability of FG to attenuate STZ-induced ß-cell damage was demonstrated by modulating the activity of immune response.…”
Section: Discussionmentioning
confidence: 67%
“…In the STZ-induced diabetic model, hyperglycemia arises from the irreversible destruction of pancreatic ß-cells through free radicals and nitric oxide (NO), causing degranulation and reduction of insulin secretion (3). Many effects of STZ on pancreatic islets are similar to those exerted by interleukin-1ß (IL-1ß) and some studies indicate that IL-1ß-induced islet injury as well as STZ-induced islet cytotoxicity are mediated by NO production (4,5).…”
Section: Introductionmentioning
confidence: 99%
“…There was a significant increase in SOD, CAT and GSH-px It was reported that diabetic subjects are highly sensitive to oxidative stress (Pritchard et al, 1986). In STZ-diabetic animals, STZ generates nitric oxide, which is a powerful free radical oxidant (Kwon et al, 1994) resulting in an increase in blood glucose level. Several studies have documented the relationships between the increase of free radicals and blood glucose, lipid peroxidation as well as low-density lipoprotein in the progress of diabetes (Rabinovitch et al, 1996;Tanaka et al, 2002).…”
Section: Determination Of Tissue Antioxidative Enzyme Activitiesmentioning
confidence: 99%